Learn More
Medchemexpress LLC RAPTA-C (Ru(η6-p-cymene)Cl2(pta)) | 372948-28-2 | 99.3% | 1 MG

Supplier: Medchemexpress LLC HY1303261MG
RAPTA-C acts as an anti-cancer and anti-angiogenic agent. It exhibits anti-metastatic, anti-angiogenic, and anti-tumoral activities through protein and histone-deoxyribonucleic acid alterations.
- Inhibits cell growth by triggering G(2)/M phase arrest in cancer cells
- Enhances p53 levels
- Triggers the mitochondrial apoptotic pathway
- Reduces tumor growth with inhibition of angiogenesis in an ovarian carcinoma model
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.